Josephine M Forbes Selected Research

Josephine M Forbes Research Topics

Disease

38	Diabetic Nephropathies (Diabetic Nephropathy) 12/2023 - 11/2002
20	Albuminuria 01/2020 - 05/2002
16	Inflammation (Inflammations) 12/2023 - 04/2008
15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 08/2005
11	Fibrosis (Cirrhosis) 01/2022 - 09/2003
10	Type 2 Diabetes Mellitus (MODY) 09/2020 - 04/2009
8	Insulin Resistance 01/2022 - 08/2005
7	Obesity 06/2022 - 08/2005
7	Hyperglycemia 11/2020 - 08/2005
7	Diabetes Complications 09/2020 - 03/2003
6	Kidney Diseases (Kidney Disease) 06/2022 - 01/2013
6	Atherosclerosis 11/2020 - 07/2004
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 08/2013
5	Chronic Disease (Chronic Diseases) 01/2020 - 07/2011
4	Chronic Renal Insufficiency 12/2023 - 01/2016
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 02/2012
4	Critical Illness (Critically Ill) 01/2022 - 04/2018
4	Hypertension (High Blood Pressure) 11/2021 - 05/2002
4	Body Weight (Weight, Body) 01/2018 - 07/2013
4	Proteinuria 02/2016 - 05/2002
3	Overweight 11/2021 - 06/2016
3	Prediabetic State (Prediabetes) 06/2021 - 04/2015
3	Non-alcoholic Fatty Liver Disease 10/2019 - 04/2014
3	Hypertrophy 08/2008 - 09/2003
2	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 04/2018
2	Necrosis 01/2022 - 01/2017
2	Dyslipidemias (Dyslipidemia) 11/2021 - 09/2010
2	Sclerosis 07/2021 - 09/2010
2	Experimental Diabetes Mellitus 01/2021 - 03/2003
2	Neoplasms (Cancer) 04/2020 - 05/2013
2	Hypoxia (Hypoxemia) 01/2020 - 01/2018
2	Disease Progression 10/2019 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2016 - 04/2014
2	Fatty Liver 09/2016 - 04/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2013 - 04/2009
2	Vascular Diseases (Vascular Disease) 05/2013 - 09/2009
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Glucose Intolerance 11/2021

Drug/Important Bio-Agent (IBA)

40	Advanced Glycation End ProductsIBA 11/2022 - 11/2002
15	Receptor for Advanced Glycation End ProductsIBA 12/2023 - 08/2005
15	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 08/2005
11	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2002
10	Insulin (Novolin)FDA Link 01/2022 - 09/2005
10	alagebriumIBA 06/2021 - 04/2003
7	Dietary Advanced Glycation End ProductsIBA 06/2022 - 03/2010
6	AlbuminsIBA 01/2021 - 09/2003
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 02/2008
6	Superoxides (Superoxide)IBA 04/2014 - 08/2008
5	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2022 - 09/2009
5	LipidsIBA 01/2022 - 04/2008
5	CollagenIBA 07/2021 - 08/2004
5	CreatinineIBA 01/2021 - 09/2009
5	Adenosine Triphosphate (ATP)IBA 01/2020 - 03/2010
5	AntioxidantsIBA 08/2013 - 03/2007
4	ChloridesIBA 06/2021 - 08/2008
4	Apolipoproteins E (ApoE)IBA 09/2010 - 07/2004
3	LigandsIBA 01/2023 - 08/2010
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2012
3	ApolipoproteinsIBA 01/2021 - 07/2004
3	CholesterolIBA 11/2020 - 04/2008
3	GlycogenIBA 04/2020 - 01/2015
3	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2019 - 01/2016
3	CarbohydratesIBA 01/2019 - 04/2018
3	Biomarkers (Surrogate Marker)IBA 02/2016 - 01/2011
3	Ramipril (Altace)FDA LinkGeneric 01/2014 - 06/2003
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2010 - 02/2008
3	AngiotensinsIBA 01/2010 - 03/2003
3	CytokinesIBA 04/2008 - 12/2002
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023 - 09/2020
2	C-Reactive ProteinIBA 01/2022 - 01/2017
2	EnzymesIBA 01/2022 - 03/2003
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2022 - 09/2016
2	Syntex adjuvant formulationIBA 01/2021 - 01/2015
2	Complement C5a (Complement 5a)IBA 01/2021 - 01/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2020 - 09/2010
2	Hormones (Hormone)IBA 09/2020 - 01/2018
2	Liver GlycogenIBA 01/2017 - 01/2015
2	Triglycerides (Triacylglycerol)IBA 01/2017 - 04/2014
2	Glutathione PeroxidaseIBA 02/2016 - 06/2003
2	empagliflozinIBA 01/2016 - 01/2016
2	Streptozocin (Streptozotocin)FDA Link 09/2010 - 07/2004
2	NF-kappa B (NF-kB)IBA 06/2009 - 08/2004
2	Protein Kinase C-alphaIBA 02/2008 - 11/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2007 - 11/2004
2	Protein Kinase CIBA 11/2004 - 12/2003
2	Protein Isoforms (Isoforms)IBA 11/2004 - 12/2003
2	Fibronectins (Fibronectin)IBA 11/2004 - 12/2002
2	Angiotensin IIIBA 08/2004 - 01/2003
2	pimagedine (aminoguanidine)IBA 07/2004 - 12/2002
1	Liraglutide FDA Link 12/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 12/2023
1	Glucagon (Glukagon)FDA Link 01/2023
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2022
1	InflammasomesIBA 01/2022
1	Dietary ProteinsIBA 11/2021
1	ProteomeIBA 07/2021

Therapy/Procedure

18	Therapeutics 12/2023 - 03/2005
3	Glycemic Control 07/2011 - 11/2005
2	Drug Therapy (Chemotherapy) 06/2021 - 04/2020